Published in Proc Natl Acad Sci U S A on August 29, 2011
Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression | NCT02035878
The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients | NCT03403907
Effects of Probiotics on Mood | NCT03539263
Role of the Gut Microbiome in Complex Regional Pain Syndrome | NCT03612193
Neurocognitive Effects of FMT in MDD Patients With and Without IBS | NCT05174273
Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell (2013) 8.11
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci (2012) 4.95
The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol (2012) 2.83
Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology (2013) 2.26
Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring. Cell (2016) 2.05
The intestinal microbiome in early life: health and disease. Front Immunol (2014) 1.90
Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biol Psychiatry (2014) 1.75
Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev (2012) 1.68
Gut/brain axis and the microbiota. J Clin Invest (2015) 1.64
Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays (2014) 1.64
Brain-gut-microbe communication in health and disease. Front Physiol (2011) 1.59
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience (2013) 1.55
Depression, antidepressant medications, and risk of Clostridium difficile infection. BMC Med (2013) 1.54
Exploring host-microbiota interactions in animal models and humans. Genes Dev (2013) 1.51
Control of brain development, function, and behavior by the microbiome. Cell Host Microbe (2015) 1.48
Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci (2014) 1.47
Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One (2013) 1.40
The effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry (2017) 1.38
Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol (2013) 1.35
The role of microbiome in central nervous system disorders. Brain Behav Immun (2013) 1.34
Exercise attenuates PCB-induced changes in the mouse gut microbiome. Environ Health Perspect (2013) 1.33
Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis (2015) 1.33
Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A (2014) 1.31
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry (2015) 1.29
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol (2015) 1.25
The microbiome: stress, health and disease. Mamm Genome (2013) 1.24
Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One (2013) 1.24
Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology (2014) 1.22
Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse. PLoS One (2012) 1.21
The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Front Integr Neurosci (2013) 1.17
Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides (2012) 1.16
Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog (2013) 1.13
Mechanisms underlying the effects of prenatal psychosocial stress on child outcomes: beyond the HPA axis. Eur Child Adolesc Psychiatry (2014) 1.13
Specialized metabolites from the microbiome in health and disease. Cell Metab (2014) 1.12
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes (2012) 1.12
An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe (2015) 1.11
The microbiome revolution. J Clin Invest (2014) 1.11
Regulation of prefrontal cortex myelination by the microbiota. Transl Psychiatry (2016) 1.09
Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition. Mol Neurodegener (2014) 1.08
Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe (2014) 1.08
Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci (2015) 1.06
Experimental approaches for defining functional roles of microbes in the human gut. Annu Rev Microbiol (2013) 1.06
The gut microbiome and the brain. J Med Food (2014) 1.06
Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol (2014) 1.06
Toward effective probiotics for autism and other neurodevelopmental disorders. Cell (2013) 1.06
Gastrointestinal hormones and the dialogue between gut and brain. J Physiol (2014) 1.03
Metagenomics and novel gene discovery: promise and potential for novel therapeutics. Virulence (2013) 1.03
Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol (2014) 1.00
The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev (2015) 0.99
Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls. PeerJ (2015) 0.99
Predicting the impact of diet and enzymopathies on human small intestinal epithelial cells. Hum Mol Genet (2013) 0.99
Pathogenesis of Parkinson disease-the gut-brain axis and environmental factors. Nat Rev Neurol (2015) 0.98
Probiotic bacteria induce a 'glow of health'. PLoS One (2013) 0.98
Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes (2013) 0.97
Modulatory Effects of Gut Microbiota on the Central Nervous System: How Gut Could Play a Role in Neuropsychiatric Health and Diseases. J Neurogastroenterol Motil (2016) 0.97
Eco-Evo-Devo: developmental symbiosis and developmental plasticity as evolutionary agents. Nat Rev Genet (2015) 0.97
Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms. J Physiol (2014) 0.96
Fermented foods, microbiota, and mental health: ancient practice meets nutritional psychiatry. J Physiol Anthropol (2014) 0.96
Gut bacteria in health and disease. Gastroenterol Hepatol (N Y) (2013) 0.95
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clin Ther (2015) 0.95
Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol (2014) 0.95
Psychobiotics and the gut-brain axis: in the pursuit of happiness. Neuropsychiatr Dis Treat (2015) 0.95
Early-life exercise may promote lasting brain and metabolic health through gut bacterial metabolites. Immunol Cell Biol (2015) 0.94
Functional profiling of the gut microbiome in disease-associated inflammation. Genome Med (2013) 0.93
Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl) (2014) 0.93
Microbial endocrinology: Host-microbiota neuroendocrine interactions influencing brain and behavior. Gut Microbes (2014) 0.92
Impact of the gut microbiota on rodent models of human disease. World J Gastroenterol (2014) 0.92
Mechanisms of non-genetic inheritance and psychiatric disorders. Neuropsychopharmacology (2014) 0.92
Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat Commun (2013) 0.91
Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol (2016) 0.91
Gut microbiota and developmental programming of the brain: from evidence in behavioral endophenotypes to novel perspective in obesity. Front Cell Infect Microbiol (2012) 0.91
Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression. Psychol Bull (2014) 0.90
Gut microbial communities modulating brain development and function. Gut Microbes (2012) 0.90
The Central Nervous System and the Gut Microbiome. Cell (2016) 0.90
A possible link between food and mood: dietary impact on gut microbiota and behavior in BALB/c mice. PLoS One (2014) 0.89
Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder. Biol Psychiatry (2016) 0.89
Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLoS One (2014) 0.89
Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial. Prim Care Companion CNS Disord (2014) 0.89
The gut microbiome: scourge, sentinel or spectator? J Oral Microbiol (2012) 0.88
Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trials. Gut Pathog (2013) 0.88
Symbiosis as a general principle in eukaryotic evolution. Cold Spring Harb Perspect Biol (2014) 0.88
Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) (2016) 0.88
Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem Int (2013) 0.87
Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions. World J Gastroenterol (2014) 0.87
Important Metabolic Pathways and Biological Processes Expressed by Chicken Cecal Microbiota. Appl Environ Microbiol (2015) 0.87
The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment: Relationship to Depression, Anxiety, and Eating Disorder Psychopathology. Psychosom Med (2015) 0.87
Gut microbiota in autism and mood disorders. World J Gastroenterol (2016) 0.86
The gut microbial community of Midas cichlid fish in repeatedly evolved limnetic-benthic species pairs. PLoS One (2014) 0.86
The gastrointestinal tract microbiome and potential link to Alzheimer's disease. Front Neurol (2014) 0.86
Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. Compr Physiol (2014) 0.86
The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. J Physiol (2015) 0.86
Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome. Neuropsychopharmacology (2016) 0.86
May the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry. CNS Drugs (2016) 0.86
Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx. Sci Rep (2014) 0.86
Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2014) 0.85
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85
Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome (2017) 0.85
Glyphosate, pathways to modern diseases III: Manganese, neurological diseases, and associated pathologies. Surg Neurol Int (2015) 0.85
Genomics of schizophrenia: time to consider the gut microbiome? Mol Psychiatry (2014) 0.85
Exercise is More Effective at Altering Gut Microbial Composition and Producing Stable Changes in Lean Mass in Juvenile versus Adult Male F344 Rats. PLoS One (2015) 0.85
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci (1992) 11.73
Genetics of mouse behavior: interactions with laboratory environment. Science (1999) 10.74
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods (1985) 9.05
Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A (2011) 6.16
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology (2005) 5.75
Sustained conditioned responses in prelimbic prefrontal neurons are correlated with fear expression and extinction failure. J Neurosci (2009) 3.76
Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol (2004) 3.52
Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci (1999) 3.36
Bacterial infection causes stress-induced memory dysfunction in mice. Gut (2010) 3.06
Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry (2008) 2.52
Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil (2010) 2.47
Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med (2008) 2.39
Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol (2004) 2.38
Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr (2010) 2.30
Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol (2009) 2.24
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology (2006) 2.24
Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol (2010) 2.22
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med (2006) 2.16
Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther (2008) 2.13
The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil (2011) 1.87
Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology (2010) 1.85
Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression. Trends Pharmacol Sci (2005) 1.84
A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog (2009) 1.74
cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci (2002) 1.71
Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut (2007) 1.69
Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun (2004) 1.64
Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun (2005) 1.46
The significance of glucocorticoid pulsatility. Eur J Pharmacol (2008) 1.45
Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav (2006) 1.43
Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. J Anxiety Disord (2008) 1.27
Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut (2005) 1.27
Mood and gut feelings. Brain Behav Immun (2009) 1.27
Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol (2009) 1.23
GABAB receptor antagonist SGS742 improves spatial memory and reduces protein binding to the cAMP response element (CRE) in the hippocampus. Neuropharmacology (2005) 1.11
Luminal administration ex vivo of a live Lactobacillus species moderates mouse jejunal motility within minutes. FASEB J (2010) 1.08
Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Int J Neuropsychopharmacol (2010) 1.07
GABA(B(1)) receptor isoforms differentially mediate the acquisition and extinction of aversive taste memories. J Neurosci (2006) 1.05
Efficacy of vagus nerve stimulation in the treatment of depression. Expert Rev Neurother (2010) 1.05
GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent. J Pharmacol Exp Ther (2004) 1.02
Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. Am J Physiol Regul Integr Comp Physiol (2008) 1.00
Juvenile stress-induced alteration of maturation of the GABAA receptor alpha subunit in the rat. Int J Neuropsychopharmacol (2008) 0.99
Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety. Psychopharmacology (Berl) (2006) 0.99
The alpha1 subunit of the GABA(A) receptor modulates fear learning and plasticity in the lateral amygdala. Front Behav Neurosci (2009) 0.99
Corticosterone facilitates extinction of fear memory in BALB/c mice but strengthens cue related fear in C57BL/6 mice. Exp Neurol (2008) 0.98
Specific roles of GABA(B(1)) receptor isoforms in cognition. Behav Brain Res (2007) 0.98
Vagus nerve stimulation potentiates hippocampal LTP in freely-moving rats. Physiol Behav (2007) 0.97
Evidence for a role of GABAA receptor in the acute restraint stress-induced enhancement of spatial memory. Brain Res (2007) 0.95
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci (2012) 4.95
Differential compartmentalization and distinct functions of GABAB receptor variants. Neuron (2006) 2.53
Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry (2008) 2.52
Psychobiotics: a novel class of psychotropic. Biol Psychiatry (2013) 2.46
Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med (2008) 2.39
Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med (2007) 1.75
The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res (2008) 1.74
Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology (2006) 1.73
Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology (2004) 1.72
cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci (2002) 1.71
Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol (2014) 1.71
Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J Neurosci (2004) 1.66
Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun (2004) 1.64
Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc (2012) 1.59
Brain-gut-microbe communication in health and disease. Front Physiol (2011) 1.59
Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc Natl Acad Sci U S A (2004) 1.58
Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol (2006) 1.53
Interleukin-10 and nerve growth factor have reciprocal upregulatory effects on intestinal epithelial cells. Am J Physiol Regul Integr Comp Physiol (2003) 1.52
Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology (2012) 1.47
Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res (2006) 1.46
Prolactin and dopamine: what is the connection? A review article. J Psychopharmacol (2008) 1.45
Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med (2009) 1.44
Proteinase-activated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways. J Allergy Clin Immunol (2005) 1.37
A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proc Natl Acad Sci U S A (2005) 1.35
Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci (2003) 1.34
Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model. J Allergy Clin Immunol (2008) 1.34
Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol (2004) 1.33
Irritable bowel syndrome: towards biomarker identification. Trends Mol Med (2009) 1.29
Mood and gut feelings. Brain Behav Immun (2009) 1.27
Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev (2011) 1.25
The microbiome: stress, health and disease. Mamm Genome (2013) 1.24
Antidepressant therapy and C-reactive protein levels. Br J Psychiatry (2006) 1.24
Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord (2006) 1.24
Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol (2009) 1.23
The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learning. Biol Psychiatry (2007) 1.20
A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol (2010) 1.18
Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology (Berl) (2010) 1.17
Lithium in bipolar mood disorder. BMJ (2002) 1.16
The spermatogenic Ig superfamily/synaptic cell adhesion molecule mast-cell adhesion molecule promotes interaction with nerves. J Immunol (2005) 1.16
Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol (2012) 1.15
Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice. J Neurosci (2006) 1.13
Immunomodulation by commensal and probiotic bacteria. Immunol Invest (2010) 1.13
Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol (2008) 1.11
Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes. Neuropsychopharmacology (2012) 1.11
A review of candidate pathways underlying the association between asthma and major depressive disorder. Psychosom Med (2008) 1.10
Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol (2010) 1.10
Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology (Berl) (2012) 1.09
Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? Brain Behav Immun (2011) 1.09
The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol (2014) 1.08
Luminal administration ex vivo of a live Lactobacillus species moderates mouse jejunal motility within minutes. FASEB J (2010) 1.08
Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Int J Neuropsychopharmacol (2010) 1.07
Evaluation of reward processes in an animal model of depression. Psychopharmacology (Berl) (2006) 1.07
Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol (2009) 1.07
Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol (2014) 1.06
Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist. J Pharmacol Exp Ther (2002) 1.06
Effects of intestinal microbiota on anxiety-like behavior. Commun Integr Biol (2011) 1.05
GABA(B(1)) receptor isoforms differentially mediate the acquisition and extinction of aversive taste memories. J Neurosci (2006) 1.05
Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits. Neuroreport (2005) 1.05
Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis (2012) 1.04
The association between depression and anxiety disorders following facial trauma--a comparative study. Injury (2010) 1.04
Evidence against the involvement of chronic cerebrospinal venous abnormalities in multiple sclerosis. A case-control study. PLoS One (2013) 1.04
Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology (2006) 1.04
Functional dyspepsia: are psychosocial factors of relevance? World J Gastroenterol (2006) 1.03
The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology (2005) 1.02
Transient inactivation of the infralimbic cortex induces antidepressant-like effects in the rat. J Psychopharmacol (2010) 1.02
Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev (2011) 1.02
GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent. J Pharmacol Exp Ther (2004) 1.02
Ghrelin signalling and obesity: at the interface of stress, mood and food reward. Pharmacol Ther (2012) 1.02
Vagal pathways for microbiome-brain-gut axis communication. Adv Exp Med Biol (2014) 1.02
The vagus nerve modulates CD4+ T cell activity. Brain Behav Immun (2009) 1.01
Sexually dimorphic effects of maternal separation stress on corticotrophin-releasing factor and vasopressin systems in the adult rat brain. Int J Dev Neurosci (2008) 1.01
Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes (2013) 1.01
Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. Am J Physiol Regul Integr Comp Physiol (2008) 1.00
Distinct alterations in colonic morphology and physiology in two rat models of enhanced stress-induced anxiety and depression-like behaviour. Stress (2010) 1.00